Lyfegen Raises $8M for Value-Based Contracting for High-Cost Drugs
HIT Consultant
SEPTEMBER 20, 2022
Founded in 2018, Lyfegen’s platform helps regulators, pharma companies and payers more easily adopt value-based payment models by digitizing the end-to-end process of data collection, anonymization and contract negotiations for all parties to agree upon drug pricing and reimbursement.
Let's personalize your content